Roche today announced that the first in class Hedgehog pathway inhibitor vismodegib, was named Drug Discovery of the Year by the British Pharmacological Society.
20 December, 2012
Alacrita, the transatlantic firm which is changing the face of life science consulting, is delighted to launch its 2012 Life Sciences Seasonal Appeal. Alacrita is offering the unique opportunity for individuals from the life sciences industry to bid for a two-hour, one-to-one lunch with senior executives from the pharmaceutical industry.
10 December, 2012